Markets
DaVita Stock Tumbles 6%, Wiping Out $787 Million, After Narrowed Profit Outlook And China Charge
The dialysis provider narrowed its 2026 profit guidance, and its CFO said the payment-rule boost fades after the first quarter.
DaVita (DVA) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Markets
The dialysis provider narrowed its 2026 profit guidance, and its CFO said the payment-rule boost fades after the first quarter.
Earnings
CFO Joel Ackerman puts the net 2027 benefit at 1.5% to 2%, and says technology spending will keep growing.
Earnings
Javier Rodriguez pushed back on how HHS's kidney plan portrays dialysis, citing 90% government coverage and about 1% Medicare increases.
Insider Trades
Berkshire and Warren Buffett still report 28.3 million DaVita shares after Tuesday's open-market sale at an average $180.43.
Earnings
Adjusted operating income was $561 million in the third quarter, while cash flow fell well below a year earlier.
SEC Filings
The dialysis giant's quarterly report lists China as its only reporting unit still at risk, a quarter after naming none.